252 related articles for article (PubMed ID: 32580499)
1. Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer's Disease with APP Osaka Mutation.
Shimada H; Minatani S; Takeuchi J; Takeda A; Kawabe J; Wada Y; Mawatari A; Watanabe Y; Shimada H; Higuchi M; Suhara T; Tomiyama T; Itoh Y
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580499
[TBL] [Abstract][Full Text] [Related]
2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
3. Progress of Brain Amyloid Deposition in Familial Alzheimer's Disease with Taiwan D678H APP Mutation.
Weng YC; Hsiao IT; Huang CY; Huang KL; Liu CH; Chang TY; Yen TC; Lin KJ; Huang CC
J Alzheimers Dis; 2018; 66(2):775-787. PubMed ID: 30320594
[TBL] [Abstract][Full Text] [Related]
4. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.
Gallardo G; Holtzman DM
Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039
[TBL] [Abstract][Full Text] [Related]
6. Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice.
Umeda T; Kimura T; Yoshida K; Takao K; Fujita Y; Matsuyama S; Sakai A; Yamashita M; Yamashita Y; Ohnishi K; Suzuki M; Takuma H; Miyakawa T; Takashima A; Morita T; Mori H; Tomiyama T
Acta Neuropathol Commun; 2017 Jul; 5(1):59. PubMed ID: 28760161
[TBL] [Abstract][Full Text] [Related]
7. APP Osaka Mutation in Familial Alzheimer's Disease-Its Discovery, Phenotypes, and Mechanism of Recessive Inheritance.
Tomiyama T; Shimada H
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093100
[TBL] [Abstract][Full Text] [Related]
8. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease.
Iaccarino L; Tammewar G; Ayakta N; Baker SL; Bejanin A; Boxer AL; Gorno-Tempini ML; Janabi M; Kramer JH; Lazaris A; Lockhart SN; Miller BL; Miller ZA; O'Neil JP; Ossenkoppele R; Rosen HJ; Schonhaut DR; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2018; 17():452-464. PubMed ID: 29159058
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein.
Shimada H; Ataka S; Tomiyama T; Takechi H; Mori H; Miki T
Dement Geriatr Cogn Disord; 2011; 32(1):45-54. PubMed ID: 21846988
[TBL] [Abstract][Full Text] [Related]
10. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
[TBL] [Abstract][Full Text] [Related]
11. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
[TBL] [Abstract][Full Text] [Related]
12. A Novel AβPP M722K Mutation Affects Amyloid-β Secretion and Tau Phosphorylation and May Cause Early-Onset Familial Alzheimer's Disease in Chinese Individuals.
Wang Q; Jia J; Qin W; Wu L; Li D; Wang Q; Li H
J Alzheimers Dis; 2015; 47(1):157-65. PubMed ID: 26402764
[TBL] [Abstract][Full Text] [Related]
13. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
[TBL] [Abstract][Full Text] [Related]
14. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
Gandy S; Petanceska S
Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
[TBL] [Abstract][Full Text] [Related]
16. Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.
Smith R; Wibom M; Olsson T; Hägerström D; Jögi J; Rabinovici GD; Hansson O
J Alzheimers Dis; 2016; 51(2):339-43. PubMed ID: 26836192
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease families with amyloid precursor protein mutations.
Rossor MN; Newman S; Frackowiak RS; Lantos P; Kennedy AM
Ann N Y Acad Sci; 1993 Sep; 695():198-202. PubMed ID: 8239283
[TBL] [Abstract][Full Text] [Related]
18. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
Götz J; Schild A; Hoerndli F; Pennanen L
Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
[TBL] [Abstract][Full Text] [Related]
20. Different clinical and neuroimaging features of Japanese dementia siblings with a new N-terminal mutation (Val225Ala) of APP gene.
Ohta Y; Hishikawa N; Ikegami K; Sato K; Osakada Y; Takemoto M; Yamashita T; Omote Y; Ikeuchi T; Abe K
J Clin Neurosci; 2020 Feb; 72():482-484. PubMed ID: 31937505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
